Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - Total assets
Total assets on the balance sheet as of December 2023 : $1.51 B
According to Amphastar Pharmaceuticals's latest financial reports the company's total assets are $1.51 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Amphastar Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.51 B | 103.9% |
| 2022-12-31 | $0.74 B | 10.49% |
| 2021-12-31 | $0.67 B | 6.38% |
| 2020-12-31 | $0.63 B | 7.54% |
| 2019-12-31 | $0.58 B | 14.29% |
| 2018-12-31 | $0.51 B | 13.85% |
| 2017-12-31 | $0.45 B | 5.46% |
| 2016-12-31 | $0.42 B | 9.64% |
| 2015-12-31 | $0.39 B | 0.2% |
| 2014-12-31 | $0.38 B | 14.94% |
| 2013-12-31 | $0.33 B | 6.7% |
| 2012-12-31 | $0.31 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $0.13 B | -90.79% | 🇺🇸 USA |
 SCYNEXIS SCYX | $0.14 B | -90.18% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $0.17 B | -88.70% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $10.88 M | -99.28% | 🇺🇸 USA |